XBiotech

$5.59 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About XBiotech

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies for treating a variety of diseases, such as cancer, vascular disease, inflammatory skin disease, and diabetes.

Stock Analysis

last close $5.59
1-mo return -22.8%
3-mo return -43.3%
avg daily vol. 111.85T
52-week high 16.95
52-week low 5.37
market cap. $171M
forward pe -
annual div. -
roe -6.6%
ltg forecast -
dividend yield -
annual rev. $14M
inst own. 20.7%
baraka

Subscribe now for daily local and international financial news

Subscribe